
|Videos|September 22, 2021
Dr. Gao on study of resistance to PARP inhibitor olaparib in prostate cancer
Author(s)Urology Times staff
Advertisement
In this video, Allen C. Gao, MD, PhD, discusses the background and findings of the study, “
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Testosterone deficiency: FAQs from the AUA guideline
3
Joshua Lang, MD, MS, on integrating molecular biomarkers into clinical practice
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5












